If you are looking for all things newsworthy in healthcare & tech you have for sure come to the right place!
Read on below for features on Junto Members, reports on trends that we are seeing in digital health, and insight into the world of Junto Health and our mission.
Heading out of 2017 and into the New Year, the health tech battlefield is littered with countless startups who garnered investments but soon fell to the unique pressures felt in the healthcare space. At Junto, we have been able to have a sidelines view of these trials and tribulations as we have guided our larger providers and pharmaceutical members through different phases of digital innovation.
While plenty of companies have impressed us with their tenacity and drive, a few stood out for their unique vision and solutions to the healthcare ecosystem's struggles on both the clinician and patient side. Here is our roundup of 3 startups that thoroughly impressed us this year and that you should be sure to keep an eye on as we head into 2018, because they are most definitely positioned for even more success.
Adoption of technology in the healthcare field has been happening at an incredibly slow pace. This is a fact that new would disagree with. The market is saturated with health tech companies that are vying to be the next big unicorn in the field, but long sales cycles and simple underestimations of what is needed for HIPAA and FDA approval has led to the demise of many of these projects. The ones that do receive enough series funding to produce finessed products for health systems and pharmaceutical companies however soon realize that the battle against time is not over.
Simply getting into a health system is not enough. Once a contract is finally ironed out and software is exchanged, the next uphill battle against the slow-pace of internal adoption is mounted.
Recently, we caught up with serial founder Jean-Luc Neptune who is out to change the sports medicine landscape with his business partner Adam Banks.
Together, these two men have founded a new venture called Athletik Health. With countless years of experience managing startups and a background in medicine, JL sees the opportunity for a reinvention of the sports medicine landscape. Over the past few years we have all watched the rise of boutique fitness programs like Soul Cycle and a new class of ultra marathons and races. What has been missing however is a similar reinvention of the care provided for everyday individuals who are pushing their bodies to the extreme through these new exercise fads.
With Athletik Health, JL and Adam hope to make receiving care easier and to reverse the trend of underconsumption in rehabilitation medicine and physical therapy services.
Those who actually manage and work within health systems are the ones who actually see the complete picture of the health tech revolution. They also are reading about these flashy new products, but unlike us they are also privy to the inner workings and struggles that getting a product successfully integrated into a health system requires. Revolutionizing our health system is not as easy as buying a bunch of product licenses and then handing out applications to patients, but actually involves a considerable amount of thought, training, IT integration, and program roll-out.One provider system that recently went through this experience is St. Vincent's Medical Center in Bridgeport, Connecticut.
Imagine if I told you that there was a pool of close to 600,000 individuals in New York City who were ripe for innovative health technology integration. You probably wouldn’t believe me and say that it sounded too good to be true. This said pool does in fact exist and can be found concentrated within the city’s public housing.
While entrepreneurs, governmental leaders, and healthcare officials constantly speak of innovation and disruption, there seems to be a major disconnect between these words and actual creativity. This large, untapped pool of individuals who fall under the New York City Housing Authority’s (NYCHA) umbrella is one example of the lack of creative and truly disruptive practices I see in today’s early stage ecosystem.
Countless individuals in the U.S. are fortunate to receive healthcare via their employers. There is no magical, one-size fits all program though for employers to provide for their employees. Instead, employers often shop around the private market seeking the right fit for their company. This leads to the weighing of a myriad of offerings against one another while leaders attempt to choose the best fit to create a complete healthcare experience for their employees.
Employers are increasingly realizing however that they do not need to travel down this road alone. The Northeast Business Group on Health (NEBGH) is an organization that is helping unite employers together to discuss plan coverage, and the actual needs of their employees, in hopes of improving the quality of healthcare for many Americans.
Recently, the Chief Product Officer of Celmatix, Angie Lee, gave an incredibly engaging speech at an event held by HealthTech Women called "Take Charge of Your Reproductive Health & Biological Clock". Focused on the advances in DNA and reproductive health technology, and how this information is empowering women to make smarter decisions about their health, this talk provided a platform for a topic that is often pushed to the side and behind closed doors.
Inspired by the speech she gave, we asked Angie to expand further on her thoughts about the importance of presenting data in an approachable manner to address infertility by authoring a guest article for us.
In 2015, Julia Cheek founded a home health testing platform, EverlyWell, that has received acclaim from TechCrunch, CBS, Fast Company, and the Harvard Business School. Based in Austin, TX, EverlyWell has raised $5 million to date and is one of the fastest-growing consumer healthcare startups in recent history. They’ve reached millions in sales in just one year after launching in beta and in 2017 Julia was named the number one female entrepreneur to watch by CIO magazine for 2017.
With a mission of providing actionable insight regarding the biomarkers that appear on testing results so informed wellness decisions can be made, Everlywell has developed a convenient at-home process that has removed the layers of doctor appointments and difficult to understand results. Their recent partnership with Helix has also brought genomic testing to the platform, making them at the forefrongt of genomic and biomarker consumer testing.
At Junto Health we were lucky to have the chance to speak with the woman who coined the term “femtech”, Ida Tin, who is the CEO and co-founder of the female health application Clue.
Clue was founded in Berlin, Germany in 2013 when this technology movement first began to rise and has since grown its membership and reach. With a belief that “connected mobile technology is the future of female health”, Clue enables users to share information regarding menstrual cycles with partners, family, and friends. Ida took time to explain why this was an important aspect of the app’s design, and also how Clue is continuing to grow.
A group in Toronto, Canada called WinterLight Labs is beginning to break down the barriers of diagnosis and progression tracking of Alzheimer's disease with their new detection program. Based on AI technology, they have developed a way to quantify speech and language patterns so that cognitive and mental diseases can be easily detected and monitored. We spoke with one of their co-founders, Liam Kaufman, about their research and how its commercialization has the potential to revolutionize Alzheimer’s detection and maintenance.
That is the number of individuals who received their health insurance coverage via either Medicaid or Medicare programs in 2015 according to the data compiled by the CDC and Henry J. Kaiser Family Foundation. Let’s just repeat that number again- 105,692,900 Americans.
It was estimated that in 2015, there were 289,902,600 individuals with health insurance coverage. Approximately 39% of those individuals were receiving their coverage under public programs. This amounts to a significant percentage of the American population who are not being privately insured.
Why is it then that many of today’s trending health tech companies are ignoring this 39% of covered Americans when developing their innovations?
Designing digital health products can, at times, be much more complicated than developing regular technology. Not only are you dealing with the human body which can react and respond in numerous variable and unexpected ways, but you are on the front lines fighting against another force - time.
Whether it is growth or deterioration, the passing of time leads to massive changes on both a biological and a physical level. Digital health products are up against everything from microscopic cell growth and division to physically apparent weight increases and decreases. There is perhaps no stage of life where these changes are more fast-paced and important than during pregnancy.